Purpose of the development: • ENDOSPORIN highly etiotropic probiotic for treatment and prevention of intestinal infections and purulent, postpartum endometritis, delay of membranes (droppings) and other inflammatory diseases of the genital tract of farm animals. • Laktin effective environmentally friendly probiotic for the prevention of intestinal infections, combat dysbiosis, directional formation and stabilization of the microflora of the digestive tract of chickens, normalize metabolism, stabilize the body's defenses birds.

Recommended application field: Agriculture. Livestock.

Advantages over analogues: Probiotics and Endosporin Laktin harmless to humans and animals, are environmentally friendly.

The development stage readiness: Ready for application

Technical and economic effect: Implementation: Laktin tested on poultry Kiev, Kharkov and Crimea regions. Patent of Ukraine, Specification for a pilot batch, process regulations for the manufacture of an experimental batch. Endosporin has a patent of Ukraine, Specifications, instructions for use.

Description of the development:
()
Endosporin stimulate protective immune responses of the body, suppress pathogens , shortens recovery and postpartum recovery of physiological processes. The preparation consists of lyophilized viable cells of two strains of Bacillus subtilis, which complement each other in their biological activity , a stabilizer, a cryoprotectant and the dry residue of the growth medium . The composition of the probiotic lactic acid bacteria include Laktin - representatives of the normal microflora of the digestive tract of chickens . They are characterized by high biological activity, produce lactic acid, vitamins, essential amino acids . Feed supplement for livestock and poultry - Laktin - K. Lactic acid bacteria belonging to the drug, are not virulent , invasive , toxic and toxigenic properties. They are not able to accumulate in body tissues. After applying this medication do not need a waiting period . Use of the drug has no effect on conducting laboratory tests to determine the sensitivity of the representatives of the intestinal microflora to antibiotics. Contraindications to the use of the drug has not yet been revealed.

Information about newness of the development:
there are Ukrainian patents -- 2 items

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Licence's sale
Licence's sale
Technological document's sale
Creation of joint enterprise
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua